155 related articles for article (PubMed ID: 20960159)
1. Effect of concomitant progesterone administration or the effect of removal of estrogen capsule on changes caused by long-term estrogen treatment in pituitary VIP immunoreactivities.
Heinzlmann A; Köves K; Nagy GM
Endocrine; 2010 Jun; 37(3):396-402. PubMed ID: 20960159
[TBL] [Abstract][Full Text] [Related]
2. Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study.
Köves K; Gottschall PE; Görcs T; Scammell JG; Arimura A
Endocrinology; 1990 Mar; 126(3):1756-63. PubMed ID: 1689657
[TBL] [Abstract][Full Text] [Related]
3. Sexual dimorphism in the effect of concomitant progesterone administration on changes caused by long-term estrogen treatment in pituitary hormone immunoreactivities of rats.
Heinzlmann A; Koves K; Kovacs M; Csernus V
Med Sci Monit; 2011 Feb; 17(3):BR62-73. PubMed ID: 21358595
[TBL] [Abstract][Full Text] [Related]
4. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
Gómez O; Balsa JA
Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
[TBL] [Abstract][Full Text] [Related]
5. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
Carrillo AJ; Phelps CJ
Endocrinology; 1992 Aug; 131(2):964-9. PubMed ID: 1639033
[TBL] [Abstract][Full Text] [Related]
6. The characteristic change in the distribution of S-100 immunoreactive folliculostellate cells in rat anterior pituitary upon long-term estrogen treatment is prevented by concomitant progesterone treatment.
Heinzlmann A; Köves K
Endocrine; 2008 Jun; 33(3):342-8. PubMed ID: 19082791
[TBL] [Abstract][Full Text] [Related]
7. Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
Gómez O; Balsa JA
Neuroendocrinology; 2004; 80(5):324-31. PubMed ID: 15677882
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of prolactin secretion from diethylstilbestrol-induced rat prolactinoma tissue in vitro.
Maas DL; Martinson DR; Erdmann MD; Wahle JS; Hagen TC
Proc Soc Exp Biol Med; 1995 Nov; 210(2):150-5. PubMed ID: 7568285
[TBL] [Abstract][Full Text] [Related]
9. Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary.
Lam KS; Srivastava G; Lechan RM; Lee T; Reichlin S
Neuroendocrinology; 1990 Nov; 52(5):417-21. PubMed ID: 2126350
[TBL] [Abstract][Full Text] [Related]
10. Regulation of anterior pituitary galanin and vasoactive intestinal peptide by oestrogen and prolactin status.
Hammond PJ; Khandan-Nia N; Withers DJ; Jones PM; Ghatei MA; Bloom SR
J Endocrinol; 1997 Feb; 152(2):211-9. PubMed ID: 9071978
[TBL] [Abstract][Full Text] [Related]
11. Gonadal steroid modulation of basal and vasoactive intestinal polypeptide-stimulated prolactin release by turkey anterior pituitary cells.
Knapp TR; Fehrer SC; Silsby JL; Porter TE; Behnke EJ; el Halawani ME
Gen Comp Endocrinol; 1988 Nov; 72(2):226-36. PubMed ID: 3197943
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in the expression of galanin and vasoactive intestinal peptide in oestrogen-induced prolactinomas of Fischer 344 rats.
Piroli GG; Pietranera L; Grillo CA; De Nicola AF
J Neuroendocrinol; 2004 Jan; 16(1):64-71. PubMed ID: 14962078
[TBL] [Abstract][Full Text] [Related]
13. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen and tamoxifen on the ultrastructural characteristics of female rat prolactin cells as evaluated by immunogold technique.
Erensoy N; Cagatay P; Yilmazer S
Acta Histochem; 2005; 107(3):199-205. PubMed ID: 15993477
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide and dopamine in the hypothalamus and pituitary of ageing rats with prolactinomas.
Prysor-Jones RA; Silverlight JJ; Jenkins JS; Merry BJ
Acta Endocrinol (Copenh); 1987 Sep; 116(1):150-4. PubMed ID: 3661055
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.
Maas DL; Meier DA; Wahle JS; Martinson DR; Hagen TC
Mol Cell Neurosci; 1994 Apr; 5(2):182-8. PubMed ID: 8032686
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism.
Lam KS; Lechan RM; Minamitani N; Segerson TP; Reichlin S
Endocrinology; 1989 Feb; 124(2):1077-84. PubMed ID: 2912685
[TBL] [Abstract][Full Text] [Related]
18. Anterior pituitary vasoactive intestinal peptide mRNA is colocalised with prolactin mRNA in hyperoestrogenised rats.
Chew LJ; Seah V; Murphy D; Carter D
J Mol Endocrinol; 1996 Jun; 16(3):211-20. PubMed ID: 8782079
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen-induced hyperprolactinemia on endocrine and sexual functions in adult male rats.
Bartke A; Doherty PC; Steger RW; Morgan WW; Amador AG; Herbert DC; Siler-Khodr TM; Smith MS; Klemcke HG; Hymer WC
Neuroendocrinology; 1984 Aug; 39(2):126-35. PubMed ID: 6382042
[TBL] [Abstract][Full Text] [Related]
20. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
